These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3338661)
1. Treatment of recurrent and metastatic cervical cancer with cis-platin, doxorubicin, and cyclophosphamide. Hoffman MS; Roberts WS; Bryson SC; Kavanagh JJ; Cavanagh D; Lyman GH Gynecol Oncol; 1988 Jan; 29(1):32-6. PubMed ID: 3338661 [TBL] [Abstract][Full Text] [Related]
2. Cis-platinum-adriamycin-cyclophosphamide in the treatment of advanced-recurrent cervical cancer. Villalon AH; Lu-Lim JY; Esteba DV; Manalo A; Sotto L; Jimenez MV; Agustin BM Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):660-4. PubMed ID: 3841763 [TBL] [Abstract][Full Text] [Related]
3. Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate. Hoffman MS; Roberts WS; Cavanagh D; Praphat H; Solomon P; Lyman GH Gynecol Oncol; 1989 Oct; 35(1):75-7. PubMed ID: 2477317 [TBL] [Abstract][Full Text] [Related]
4. A phase II evaluation of cisplatin, bleomycin, and mitomycin-C in patients with recurrent squamous cell carcinoma of the cervix. Hoffman MS; Kavanagh JJ; Roberts WS; LaPolla JP; Fiorica JV; Hewitt S; Cavanagh D Gynecol Oncol; 1991 Feb; 40(2):144-6. PubMed ID: 1707024 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapy with cis-platin, doxorubicin, and cyclophosphamide (CAP) in patients with metastatic breast cancer. Colozza M; Gori S; Mosconi AM; Belsanti V; Basurto C; Rossetti R; Di Costanzo F; Buzzi F; Bacchi M; Davis S Am J Clin Oncol; 1989 Apr; 12(2):137-41. PubMed ID: 2705403 [TBL] [Abstract][Full Text] [Related]
6. Cis-platinum, doxorubicin, and methotrexate treatment for recurrent cervical cancer. Wheelock JB; Krebs HB; Goplerud DR; Myers M Obstet Gynecol; 1985 Sep; 66(3):410-2. PubMed ID: 4040622 [TBL] [Abstract][Full Text] [Related]
8. Combination cyclophosphamide, adriamycin, and cis-platinum in recurrent and metastatic cervical carcinoma. De Murua EO; George M; Pejovic MH; Dewailly J; Wolff JP Gynecol Oncol; 1987 Feb; 26(2):225-7. PubMed ID: 3804038 [TBL] [Abstract][Full Text] [Related]
9. Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina. Long HJ; Cross WG; Wieand HS; Webb MJ; Mailliard JA; Kugler JW; Tschetter LK; Kardinal CG; Ebbert LP; Rayson S Gynecol Oncol; 1995 May; 57(2):235-9. PubMed ID: 7729741 [TBL] [Abstract][Full Text] [Related]
10. Chemotherapy of advanced squamous carcinoma of the cervix: a phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the Gynecologic Oncology Group. Jobson VW; Muss HB; Thigpen JT; Homesley HD; Bundy B Am J Clin Oncol; 1984 Aug; 7(4):341-5. PubMed ID: 6540048 [TBL] [Abstract][Full Text] [Related]
11. [Combination chemotherapy with PAP (peplomycin, adriamycin and cisplatin) in recurrent uterine cervical cancer with pulmonary metastasis]. Fujii M; Okabe K; Toki H; Araki Y; Masaoka H Gan To Kagaku Ryoho; 1984 Feb; 11(2):342-3. PubMed ID: 6198971 [TBL] [Abstract][Full Text] [Related]
12. [The immediate results of the combined chemotherapy of disseminated forms and recurrences of cervix uteri cancer with vincristine, platidiam and adriamycin]. Zabunov AV; Dudareva LA Vopr Onkol; 1991; 37(11-12):1090-4. PubMed ID: 1669203 [TBL] [Abstract][Full Text] [Related]
13. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck. Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121 [TBL] [Abstract][Full Text] [Related]
14. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. Loehrer PJ; Kim K; Aisner SC; Livingston R; Einhorn LH; Johnson D; Blum R J Clin Oncol; 1994 Jun; 12(6):1164-8. PubMed ID: 8201378 [TBL] [Abstract][Full Text] [Related]
15. Single agent versus combination chemotherapy in recurrent cervical cancer. Kumar L; Pokharel YH; Kumar S; Singh R; Rath GK; Kochupillai V J Obstet Gynaecol Res; 1998 Dec; 24(6):401-9. PubMed ID: 10063235 [TBL] [Abstract][Full Text] [Related]
16. Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix. Choi CH; Kim TJ; Lee SJ; Lee JW; Kim BG; Lee JH; Bae DS Int J Gynecol Cancer; 2006; 16(3):1157-64. PubMed ID: 16803500 [TBL] [Abstract][Full Text] [Related]
17. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma. Shin DM; Fossella FV; Umsawasdi T; Murphy WK; Chasen MH; Walsh G; Komaki R; McMurtrey MJ; Hong WK Cancer; 1995 Dec; 76(11):2230-6. PubMed ID: 8635025 [TBL] [Abstract][Full Text] [Related]